Samantha Hol

Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity

Tom van Meerten, Rozemarijn S. van Rijn, Samantha Hol et al. · Clinical Cancer Research · 2006 · 246 citations · Full text

Medicine, Immunology, Oncology +13

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

Wouter Scheper, Suzanne van Dorp, Sabina Kersting et al. · Leukemia · 2013 · 183 citations

Life Sciences, Cancer Biology, Immunology +11

Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells

Peter J.M. Valk, Sandra Verbakel, Yolanda Vankan et al. · Blood · 1997 · 102 citations · Full text

Medicine, Hematology, Pharmacology +9

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

Cordula Gründer, Suzanne van Dorp, Samantha Hol et al. · Blood · 2012 · 86 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909

Jürgen Kuball, Karin Boer, Eva Wagner et al. · Cancer Immunology Immunotherapy · 2010 · 72 citations · Full text

Medicine, Immunology, Oncology +17